Mesenchymal Stem Cell and Islet Co-transplantation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to show safety and tolerability to our mesenchymal stromal cells (MSCs) product which will be autologous in nature, expanded using a non-xenogeneic, human component expansion media (pooled human platelet lysate) and delivered fresh. Subsequently, the investigators intend to test whether infusion of MSCs immediately after islet autograft can reduce onset of diabetes and improve glycemic control after total pancreatectomy and islet autotransplantation.
Epistemonikos ID: 9f717beee22e799d956e34b3174d500c5bfa7eb9
First added on: May 12, 2024